Humana (HUM) Stock: Buy, Sell, or Hold?
HUM - Humana Inc.
$409.80
9.07 (2.26%)
▲
5d:
+0.81%
30d:
+5.39%
90d:
+11.15%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 4, 2026 at $401.54 · last confirmed Sep 11, 2026
Strength: 7.0/10
Get Alerted When HUM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HUM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HUM shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$613.01
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$380.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HUM is currently trading at $409.80, which is considered extended relative to its 30-day fair value range of $374.37 to $397.23. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.7) compared to its historical average (19.0). At these levels, the market is pricing in 9.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HUM is in a strong uptrend. The price is approaching resistance at $419.97. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HUM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HUM is in a strong uptrend. The price is approaching resistance at $419.97. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HUM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$374.37 -
$397.23
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.9%
Protect Your Profits
Holding HUM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($418.61)
- NEUTRAL: Trading at premium valuation - market expects 9.2% growth which is achievable
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$374.37 -
$397.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$382.11
Resistance Level
$419.97
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.73
Wall Street Target
$418.61
(+2.1%)
Revenue Growth (YoY)
26.2%
Earnings Growth (YoY)
27.1%
Profit Margin
0.9%
Valuation Premium vs History
+9.2% premium
PE vs Historical
24.7 vs 19.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.2%
(market-implied from PE analysis)
1-Year Target
$447.50
(+9%)
2-Year Target
$488.67
(+19%)
3-Year Target
$533.63
(+30%)
3-Yr Target (if PE normalizes)
(PE: 25→19)
PE COMPRESSION
$409.91
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.7, Growth: 81.0%)
$1383.08
(+238%)
Base:
(SPY PE: 20.2, Growth: 81.0%)
$1127.85
(+175%)
Bear:
(PE: 17.1, Growth: 81.0%)
$958.67
(+134%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 37.95 | Current EPS (TTM): $10.56
Bull Case
$691.59
(+69%)
Analyst growth 56.9%, PE expands to 41.7
Base Case
$628.72
(+53%)
Market implied 56.9%, PE stable at 38.0
Bear Case
$272.50
(-34%)
Severe decline -20.0%, PE contracts to 32.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 10:17 PM ET
Data refreshes hourly during market hours. Next update: 11:17 PM
Data refreshes hourly during market hours. Next update: 11:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HUM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-23
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 50 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 49 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 45 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$72 | 47 HOLD |
Advanced HUM Option Strategies
Professional options setups generated by AI based on today's HUM price and gamma walls.
